Indivior announced strategic corporate developments on July 28, 2025, including executive appointments, market strategy shifts, and FDA approval for updated labeling of SUBLOCADE.
1 report, 1 independent
Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Indivior announced strategic corporate developments on July 28, 2025, including executive appointments, market strategy shifts, and FDA approval for updated labeling of SUBLOCADE.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Indivior cancelled its secondary listing on the London Stock Exchange.Sub-event
Indivior strengthens market position with executive appointments and FDA label updates for SUBLOCADE.1 source
Keep exploring
The entities involved
-
Indivior
specialty pharmaceuticals business headquartered in Richmond, Virginia
Coverage
Newest first; wire copies grouped- Insider MonkeyIndivior PLC (INDV) Reinvents Leadership, Moves Listing to Nasdaq We recently compiled a list of 10 Best Mid Cap Stocks to Buy According to Billionaires. Indivior PLC stands seventh on our list among